Savers Value Village, Inc. SEC Filings

Savers Value Village, Inc. President & COO reports stock option exercises and share sale. On 12/18/2025, the executive exercised three stock option grants at an exercise price of $1.41 per share, acquiring 24,476, 46,822, and 111,283 shares of common stock. On the same date, 25,205 shares were disposed of in a transaction coded "F" at $9.335 per share, typically used for tax withholding, and 57,706 shares were sold in an open market transaction coded "S" at a weighted average price of $9.21 per share, within a disclosed range of $9.140 to $9.341. Following these transactions, the reporting person beneficially owned 99,712.3281 shares of Savers Value Village common stock directly, along with multiple outstanding stock option awards.

Savers Value Village investor files notice to sell common shares under Rule 144. The filing covers the planned sale of 57,706 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $531,447.16 at the time of the notice. The shares are part of a larger base of 156,227,451 common shares outstanding. The securities to be sold were acquired on 12/18/2025 through the cash exercise of stock options originally granted in 2019.

By signing the notice, the selling holder represents that they are not aware of any undisclosed material adverse information about Savers Value Village’s current or prospective operations.

Savers Value Village, Inc. (SVV) reported a new equity award to one of its directors on a Form 4. On 11/24/2025, the director received 9,090 restricted stock units (RSUs), each representing the right to receive one share of SVV common stock after vesting and settlement conditions are met.

The filing states that these RSUs will vest in a single installment on the three-month anniversary of the grant date, provided the director continues to provide services through that date. The award is reported as held directly by the reporting person and carries a stated exercise or conversion price of $0, which is typical for RSUs since they convert into shares rather than requiring a purchase price.

Savers Value Village (SVV) reported Q3 results with net sales of $426.9 million, up 8.1% year over year, driven by a 5.8% increase in comparable store sales and new store openings. U.S. net sales rose 10.5% with comps up 7.1%, while Canada net sales rose 5.1% with comps up 3.9%.

The company recorded a net loss of $14.0 million, or $0.09 per diluted share, largely due to a $32.6 million loss on extinguishment of debt tied to a September refinancing. Operating income was $36.3 million. Adjusted EBITDA was $70.0 million with a 16.4% margin.

SVV refinanced into new Senior Secured Credit Facilities, including a $750 million term loan and a $180 million revolver; the revolver had $179.1 million available as of quarter‑end. Cash was $63.5 million. The company ended the quarter with 364 stores after opening 10 new locations. Year to date, it repurchased 1.8 million shares for $15.3 million and executed a concurrent repurchase of ~2.3 million shares for $20.0 million. A new $50 million repurchase program was authorized effective November 9, 2025.

Savers Value Village (SVV) furnished an update on its results by issuing a press release covering the thirteen and thirty-nine weeks ended September 27, 2025. The company submitted this via an Item 2.02 current report.

The press release is attached as Exhibit 99.1 and, as stated, the information is furnished and not deemed “filed” under Section 18 of the Exchange Act. SVV’s common stock trades on the NYSE under the symbol SVV.

Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), reported transactions on 09/26/2025. He exercised or acquired 20,000 shares of common stock at an exercise price of $1.41 and simultaneously sold 20,000 shares under a 10b5-1 plan at a weighted average price of $13.6905 (execution prices ranged from $13.48 to $13.87). After these transactions the reporting person shows 0 shares of common stock directly owned.

Table II shows derivative holdings of options representing the right to purchase common stock at $1.41 with 364,256 shares underlying reported as beneficially owned. The filing notes that certain options are time-based (approximately 12%) and performance-based (approximately 88%), with vesting and performance conditions described for the 2019 grant.

Insider transactions by Melinda L. Geisser at Savers Value Village, Inc. (SVV). On 09/26/2025 the reporting person exercised options and sold shares under a pre-existing plan. She exercised options to acquire 20,000 shares at an exercise price of $1.41 per share, and on the same date sold 20,000 common shares pursuant to a 10b5-1 plan for a weighted-average sale price of $13.6923 per share (sales executed in a range of $13.48–$13.87). After these transactions the Form 4 reports 488,373 shares underlying previously granted options as beneficially owned (direct).

The Form 4 notes the exercised options were from the 2019 Management Incentive Plan, with the June 12, 2019 grant fully vested by March 28, 2024, and describes the composition of remaining options as ~22% time‑based and ~78% performance‑based.

Mark T. Walsh, CEO & Director of Savers Value Village, Inc. (SVV), exercised options and sold resulting shares on 09/24/2025 under a 10b5-1 plan. The filing shows Walsh acquired 34,184 shares by exercising options with a $1.41 exercise price and immediately sold 34,184 shares at a weighted average price of $13.0762, with sale prices ranging from $13.00 to $13.20. Following the transactions the reporting person holds 0 shares of common stock directly. The option grant referenced was part of the 2019 Management Incentive Plan and was fully vested as of October 7, 2024.

Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), executed option exercises and sales on 09/24/2025. He exercised 9,052 options with an exercise price of $1.41 per share, converting them into the same number of common shares. Those 9,052 shares were then sold under a 10b5-1 trading plan at a weighted average price of $13.0415 per share (execution range $12.98–$13.20). After these transactions the reporting person held 0 shares of common stock directly and reported 384,256 shares of beneficial ownership (per the filing). The filing explains the option grant schedule and that some options are performance-based and time-based.